Neos Therapeutics Garners $20,000,000 New Financing Round

  • Feed Type
  • Date
    4/23/2014
  • Company Name
    Neos Therapeutics
  • Mailing Address
    2940 N Hwy 360 Grand Prairie, TX 75050 USA
  • Company Description
    Neos Therapeutics is a specialty pharmaceutical company that focuses on time-release technologies. We have developed a broad, cutting-edge portfolio of processes that allow for tailored and independent release profiles of single and multiple ingredients.
  • Website
    http://www.neostx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The funds will support the Company’s efforts to obtain FDA approval of its three ADHD products, to expand the use of the proprietary controlled release technologies in the development of additional CR orally disintegrating tablet and CR liquid products, and to refinance its existing debt facility.
  • M&A Terms
  • Venture Investor

Trending on Xconomy

Privacy Preference Center